m6A modification variants were found in PD patients [218], and METTL3, METTL14, and YTHDF2 mRNA levels were lower in PD patients, suggesting that PD pathogenesis may be regulated via m6A modification [154]. The gene discussed is METTL3; the disease is Parkinson disease.